Clinical Trials on Type 2 Diabetes Mellitus (T2D) in United Kingdom

Total 7466 results

Eli Lilly and Company

Active, not recruiting

A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both (SURPASS-PEDS)

Glucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Type2 Diabetes | Metabolic Disease | T2DM (Type 2 Diabetes Mellitus) | T2D

United States, India, Australia, United Kingdom, Mexico, Brazil, Israel, France, Italy
NYU Langone Health

Completed

NYULMC CareSmarts Pilot

Diabetes | Type 2 Diabetes (T2D)

United States
Eli Lilly and Company

Active, not recruiting

A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1) (QWINT-1)

Type 2 Diabetes | T2D

United States, Mexico, Argentina, Puerto Rico
Washington University School of Medicine

Completed

Nutritional Therapy for Diabetic Cardiomyopathy

T2DM (Type 2 Diabetes Mellitus)

United States
Scripps Whittier Diabetes Institute
San Diego State University

Completed

Medical Assistant Health Coaching for Diabetes in Diverse Primary Care Settings (MAC)

Type 2 Diabetes Mellitus (T2DM)

United States
Novartis Pharmaceuticals

Completed

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)

Type 2 Diabetes Mellitus (T2DM)

United States
AstraZeneca
Bristol-Myers Squibb

Completed

Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State

Type 2 Diabetes Mellitus (T2DM)

United States
Ligand Pharmaceuticals
Medpace, Inc.

Completed

A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation

Type 2 Diabetes Mellitus (T2DM)

United States
Oramed, Ltd.
Integrium

Completed

A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)

United States
PhaseBio Pharmaceuticals Inc.

Completed

Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM)

United States
Oramed, Ltd.
Integrium

Terminated

A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)

United States
PegBio Co., Ltd.
Covance

Completed

Dose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus (T2DM)

United States
Northern Care Alliance NHS Foundation Trust
Brighter AB

Completed

Actiste® Diabetes Management as a Service (ADMS) Clinical Investigation (ADMSUK01)

Diabetes type1 | Diabetes type2

United Kingdom
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)

Healthy | Type 2 Diabetes Mellitus (T2DM)

United States, Singapore
East Tennessee State University
Medtronic

Terminated

Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients

T2DM (Type 2 Diabetes Mellitus) | Continuous Glucose Monitoring

United States
ConjuChem

Terminated

Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy

Type 2 Diabetes Mellitus (T2DM)

United States, Canada
Pfizer

Terminated

Multiple Dose Study Of PF-05231023 In Obese Adult Subjects

Type 2 Diabetes Mellitus (T2DM)

United States
University of Leicester

Recruiting

Format of Patient Education for Different Sociodemographic Groups

Cardiovascular Diseases | Type2 Diabetes Mellitus

United Kingdom
Pfizer

Recruiting

A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus

Obesity | Type 2 Diabetes Mellitus (T2DM)

United States
Imperial College London
AstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...

Completed

Type 2 Diabetes Exemplar: A Remote Care Service for North West London (T2DEx)

Type 2 Diabetes Mellitus

United Kingdom
Phoenix VA Health Care System
Bristol-Myers Squibb

Completed

Effects of Saxagliptin on Adipose Tissue Inflammation in Humans

Type 2 Diabetes Mellitus (T2DM)

United States
AstraZeneca
Eli Lilly and Company

Completed

A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

United Kingdom
King's College London
University College, London

Completed

Healthy Eating & Active Lifestyles for Diabetes: Feasibility Trial (HEAL-D)

Type2 Diabetes

United Kingdom
University of Leicester
University Hospitals, Leicester; Loughborough University; Baker Heart and Diabetes...

Completed

The Effects of Reducing Prolonged Sitting Bouts in Individuals at High Risk of or With Type 2 Diabetes (UP FOR 5)

Type 2 Diabetes Mellitus

United Kingdom
University Hospitals, Leicester
Department of Health, United Kingdom

Unknown

A Study to Investigate the Benefits of the Early Detection and Intensive Treatment of Type 2 Diabetes (ADDITION)

Type 2 Diabetes Mellitus

United Kingdom
Virginia Commonwealth University

Completed

Diabetes Engagement and Activation Platform (DEAP)

Type 2 Diabetes (T2D)

United States
NYU Langone Health

Completed

The Effectiveness of Resistance Training on Glycemic Control for Patients With Type 2 Diabetes in Cardiac Rehabilitation

Cardiovascular Disease | Type 2 Diabetes (T2DM)

United States
University of Aberdeen
NHS Grampian

Unknown

Assessing the Effects of a Buckwheat Beverage on Postprandial Glucose Metabolism on Healthy and T2D Individuals (BUCKFOOD)

Healthy | Type2 Diabetes

United Kingdom
University of Oxford
NIHR Collaboration for Leadership in Applied Health Research and Care (Oxford)

Completed

Type 2 Diabetes: Risk Perceptions and Self-management Behaviour

Type 2 Diabetes Mellitus

United Kingdom
AstraZeneca
Quotient Sciences

Completed

A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy Subjects

Chronic Kidney Disease | Type 2 Diabetes Mellitus (T2DM) | Non-alcoholic Steatohepatitis

United Kingdom
University of Hull

Completed

A Study to Identify Biomarkers of Hypoglycaemia in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus With Hypoglycemia

United Kingdom
University of Hull
Hull University Teaching Hospitals NHS Trust

Completed

The Effects of Hypoglycaemia in People With Type 2 Diabetes

Type 2 Diabetes Mellitus

United Kingdom
NHS Greater Glasgow and Clyde
British Heart Foundation

Completed

Physical Activity, Insulin Resistance and Function of Fat Tissue in the Offspring of Patients With Type 2 Diabetes

Cardiovascular Diseases | Type 2 Diabetes Mellitus

United Kingdom
University of Leicester
University Hospitals, Leicester

Completed

Investigating the Acute Effect of Alternative Forms of Physical Activity in a Multi-ethnic Population

Type 2 Diabetes Mellitus

United Kingdom
Imperial College Healthcare NHS Trust

Completed

Hypoglycaemia (Low Blood Sugar) in Adults With Diabetes and Adrenal Failure (HYPO-DIAD)

Diabetes Mellitus, Type 1 | Diabetes Mellitus Type 2 - Insulin-Treated | Adrenal Insufficiency

United Kingdom
Tameside General Hospital

Recruiting

Diabetes Diagnosis During Acute Admissions (FIND-IT) (FIND-IT)

Diabete Type 2

United Kingdom
University of Roehampton

Recruiting

Investigating Plasma Biomarker Molecules Associated With the Progression of Prediabetes to Overt Type 2 Diabetes

Type2 Diabetes Mellitus | Pre Diabetes

United Kingdom
University of Nottingham
Medical Research Council

Recruiting

Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets (SemVLCD)

Type 2 Diabetes Mellitus in Obese

United Kingdom
Novartis Pharmaceuticals

Completed

Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United Kingdom
University of Surrey
Novo Nordisk A/S

Completed

Detemir Energy Expenditure Study (DEES)

Obesity | Type 2 Diabetes Mellitus

United Kingdom
Alnylam Pharmaceuticals

Recruiting

A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM

Type 2 Diabetes Mellitus (T2DM)

Canada, United States
Eli Lilly and Company

Completed

Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin

Type 2 Diabetes Mellitus

United States, Spain, United Kingdom
Oviva UK Ltd
University College, London; Hull University Teaching Hospitals NHS Trust

Recruiting

SAFE-LCD Trial, for Insulin-treated Adults Living With Type 2 Diabetes

Type 2 Diabetes Treated With Insulin | Diet Habit

United Kingdom
University of Portsmouth
Portsmouth Hospitals NHS Trust

Completed

Chronic Passive Heating in Individuals With T2DM

Type2 Diabetes

United Kingdom
University of Nottingham

Completed

VLCD & Adjuvant Exercise Effect in Overweight Diabetic Men (VLCDeXDM)

Diabetes Mellitus Type 2 in Obese

United Kingdom
AstraZeneca
Eli Lilly and Company

Completed

The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females

Type 2 Diabetes Mellitus

United Kingdom
Solvay Pharmaceuticals

Completed

A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male Volunteers

Type 2 Diabetes Mellitus

United Kingdom
Solvay Pharmaceuticals

Completed

Interaction Study SLV337/Simvastatin

Type 2 Diabetes Mellitus

United Kingdom
AstraZeneca

Completed

Bioequivalence Study of Combination Tablets of Saxagliptin / Dapagliflozin / Metformin XR (Extended-release) and Dapagliflozin / Metformin XR Relative to Individual Components in Healthy Subjects

Type 2 Diabetes Mellitus

United Kingdom
AstraZeneca

Completed

Investigate the Effect of AZD1656 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Type 2 Diabetes Mellitus (T2DM) Patients

Type 2 Diabetes Mellitus

United Kingdom

Clinical Trials on Type 2 Diabetes Mellitus (T2D) in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations